Impact of the implementation of new guidelines on the management of patients with HIV infection at an advanced HIV clinic in Kinshasa, Democratic Republic of Congo (DRC).
Authors
Mangana, FMassaquoi, L D
Moudachirou, R
Harrison, R
Kaluangila, T
Mucinya, G
Ntabugi, N
van Cutsem, G
Burton, R
Isaakidis, P
Issue Date
2020-10-07Submitted date
2020-11-04
Metadata
Show full item recordJournal
BMC infectious diseasesAbstract
Background: HIV continues to be the main determinant morbidity with high mortality rates in Sub-Saharan Africa, with a high number of patients being late presenters with advanced HIV. Clinical management of advanced HIV patients is thus complex and requires strict adherence to updated, empirical and simplified guidelines. The current study investigated the impact of the implementation of a new clinical guideline on the management of advanced HIV in Kinshasa, Democratic Republic of Congo (DRC). Methods: A retrospective analysis of routine clinical data of advanced HIV patients was conducted for the periods; February 2016 to March 2017, before implementation of new guidelines, and November 2017 to July 2018, after the implementation of new guidelines. Eligible patients were patients with CD4 < 200 cell/μl and presenting with at least 1 of 4 opportunistic infections. Patient files were reviewed by a medical doctor and a committee of 3 other doctors for congruence. Statistical significance was set at 0.05%. Results: Two hundred four and Two hundred thirty-one patients were eligible for inclusion before and after the implementation of new guidelines respectively. Sex and age distributions were similar for both periods, and median CD4 were 36 & 52 cell/μl, before and after the new guidelines implementation, respectively. 40.7% of patients had at least 1 missed/incorrect diagnosis before the new guidelines compared to 30% after new guidelines, p < 0.05. Clinical diagnosis for TB and toxoplasmosis were also much improved after the implementation of new guidelines. In addition, only 63% of patients had CD4 count test results before the new guidelines compared to 99% of patients after new guidelines. Death odds after the implementation of new guidelines were significantly lower than before new guidelines in a multivariate regression model that included patients CD4 count and 10 other covariates, p < 0.05. Conclusions: Simplification and implementation of a new and improved HIV clinical guideline coupled with the installation of laboratory equipment and point of care tests potentially helped reduce incorrect diagnosis and improve clinical outcomes of patients with advanced HIV. Regulating authorities should consider developing simplified versions of guidelines followed by the provision of basic diagnostic equipment to health centers.Publisher
BMCPubMed ID
33028245Type
ArticleLanguage
enEISSN
1471-2334ae974a485f413a2113503eed53cd6c53
10.1186/s12879-020-05470-0
Scopus Count
Collections
Related articles
- "Even if she's really sick at home, she will pretend that everything is fine.": Delays in seeking care and treatment for advanced HIV disease in Kinshasa, Democratic Republic of Congo.
- Authors: Venables E, Casteels I, Manziasi Sumbi E, Goemaere E
- Issue date: 2019
- Integration and task shifting for TB/HIV care and treatment in highly resource-scarce settings: one size may not fit all.
- Authors: Van Rie A, Patel MR, Nana M, Vanden Driessche K, Tabala M, Yotebieng M, Behets F
- Issue date: 2014 Mar 1
- Prevalence, predictors, and management of advanced HIV disease among individuals initiating ART in Senegal, West Africa.
- Authors: Benzekri NA, Sambou JF, Ndong S, Tamba IT, Faye D, Diallo MB, Diatta JP, Faye K, Sall I, Sall F, Manga NM, Malomar JJ, Ndour CT, Hawes SE, Seydi M, Gottlieb GS
- Issue date: 2019 Mar 15
- Antiretroviral treatment program retention among HIV-infected children in the Democratic Republic of Congo.
- Authors: Ditekemena J, Luhata C, Bonane W, Kiumbu M, Tshefu A, Colebunders R, Koole O
- Issue date: 2014
- The Impact of Implementation Fidelity on Mortality Under a CD4-Stratified Timing Strategy for Antiretroviral Therapy in Patients With Tuberculosis.
- Authors: Patel MR, Westreich D, Yotebieng M, Nana M, Eron JJ, Behets F, Van Rie A
- Issue date: 2015 May 1